When does the mepolizumab patent expire?
The specific expiration date for mepolizumab depends on which patent (and which country) you mean, because biologics are typically protected by multiple patent families covering different aspects of the medicine and its manufacturing. Those patents can also have different expiration terms and dates by jurisdiction.
How many years of exclusivity does mepolizumab have beyond patents?
Patent expiry is not the only timing that can delay market entry for competitors. Even after patents expire, regulators and lawmakers often allow additional marketing protections (such as data/market exclusivity) that can continue to restrict competition for a period. The exact length and trigger vary by region (for example, the U.S. versus the EU), and those protections may differ from patent life.
Does mepolizumab have different patent dates in the US, Europe, and UK?
Yes. Mepolizumab’s protection dates can differ across:
- the United States (based on U.S. patent filings and any regulatory exclusivity),
- the European Union (including EU-level marketing exclusivity rules and member-state enforcement of patents),
- the UK (post-Brexit, following UK patent and regulatory frameworks).
What does “patent expiration” mean for biosimilars—can they launch immediately?
Even if a patent expires, biosimilar launch timing can still be affected by:
- whether any remaining patents still cover the product or key claims,
- whether regulatory review is completed,
- ongoing exclusivity periods tied to the reference product in that jurisdiction.
So the first approval or marketing date for a biosimilar may not align exactly with the earliest patent expiry date.
Where to check the exact mepolizumab expiration date you care about
To get the correct date, you need:
- the country/jurisdiction,
- the specific patent or patent family number,
- whether you want the earliest patent expiry or the last blocking one,
- whether you mean patent expiry or regulatory exclusivity expiry.
If you tell me the country (e.g., US, UK, EU) and whether you want “earliest possible entry” or “last remaining protection,” I can tailor the answer to the right timing framework.